A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal Cancer
This study has been completed.
Sponsor:
Veeda Oncology
Collaborators:
Bristol-Myers Squibb
Sanofi
Information provided by:
Veeda Oncology
ClinicalTrials.gov Identifier:
NCT00251485
First received: November 8, 2005
Last updated: August 20, 2008
Last verified: August 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | June 2005 |
| Primary Completion Date: | June 2005 (Final data collection date for primary outcome measure) |